Crohn Disease Clinical Trial
Official title:
Junior / Senior Concordance in Ultrasound Assessment of Crohn's Disease (ECHOCROHN)
Observational study
Crohn's disease is a chronic inflammatory disease of the intestine (IBD), evolving with
varying periods of remissions and relapses, characterized by segmental inflammation of the
digestive tract, which can be complicated by stenosis, fistulas or even digestive cancers.
The emergence of effective therapeutic strategies has led to the adoption of more ambitious
therapeutic objectives that have no longer the improvement of symptoms but a complete
cicatrization of the intestinal mucosa as an objective.
The disadvantage of the latter is the need for its evaluation by ilo-colonoscopy,
"gold-standard", invasive, not without risks (perforation, anesthesia, hemorrhage), requiring
colonic preparation and hospitalization.
In this context, the use of non-invasive markers performed in routine practice (hemogram, VS,
CRP, fibrinogen, fecal calprotectin, abdominal ultrasound), predictive of this endoscopic
mucosal healing, is a necessity to improve the tolerance of follow-up and allow better
adherence by the patient of the therapeutic project. A decrease in health costs could also be
associated with the use of these markers.
Abdominal ultrasound is an accessible, inexpensive, non-invasive and non-irradiating imaging
medium. It is very useful and has proved its effectiveness in monitoring Crohn's disease to
evaluate the activity of the disease in order to predict mucosal healing and to detect
complications (stenosis, fistula, abscess) (1, 2, 3). However, especially for the study of
the small intestine this act is known to be very dependent on the operator and the conditions
of examination (echogenicity of the patient). In addition, few objective criteria have been
described in the literature for the study of Crohn's disease (2, 3).
A recent study under submission has developed an ultrasound score of Crohn's disease
activity, which through the study of each segment (distal ileum, right colon / transverse /
left, sigmoid) using 14 criteria , allowed to rule on the activity of the disease and thus to
predict mucosal healing. In this study, which concerned 48 patients, ultrasound scans were
performed by radiologists experienced in abdominal pathology. This score was very easy to use
and powerful to study the disease activity of each segment with 2 parameters in particular:
parietal thickness and changes in fat.
It therefore seems necessary to confirm the simplicity of this ultrasound score in a
validation cohort to: in particular to study the inter-observer reproducibility so as to be
able to extend the use of this score to non-specialist radiologists.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Recruiting |
NCT05169593 -
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
|
Phase 4 | |
Recruiting |
NCT06116604 -
Early Bowel Resection for Terminal Ileal Crohn's Disease
|
||
Recruiting |
NCT05294107 -
Intestinal Organoids
|
N/A | |
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Recruiting |
NCT05627128 -
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
|
N/A | |
Withdrawn |
NCT04349449 -
ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
|
||
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Completed |
NCT03058679 -
Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease
|
N/A | |
Completed |
NCT02871635 -
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
|
Phase 3 | |
Recruiting |
NCT04539665 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
|
N/A | |
Recruiting |
NCT04266600 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
|
N/A | |
Recruiting |
NCT03913572 -
Treatment of Perianal Disease Using Adipose-derived Stem Cells
|
||
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Completed |
NCT03606499 -
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
|
||
Terminated |
NCT04102111 -
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
|
Phase 2 | |
Recruiting |
NCT04997733 -
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
|
Phase 3 | |
Recruiting |
NCT05906576 -
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
|
Phase 4 | |
Not yet recruiting |
NCT04502303 -
18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
|
Phase 2 | |
Not yet recruiting |
NCT04398836 -
Preoperative Nutrition for Crohn's Disease Patients
|
Phase 3 |